Collegium Pharmaceutical (COLL) Raw Materials (2016 - 2025)

Collegium Pharmaceutical has reported Raw Materials for 10 years, with the latest figure at $8.3 million in Q3 2025.

• On a quarterly basis, Raw Materials rose 98.31% year-over-year to $8.3 million in Q3 2025; TTM through Sep 2025 was $8.3 million, a 98.31% increase from a year earlier, with the FY2024 full-year figure at $12.5 million, up 20.68% from the prior year.
• Raw Materials was $8.3 million for Q3 2025 at Collegium Pharmaceutical, down from $9.5 million in the prior quarter.
• The five-year high for Raw Materials was $14.4 million in Q3 2023, with the low at $3.7 million in Q4 2021.
• Average Raw Materials over 5 years is $7.7 million, with a median of $7.2 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Raw Materials jumped 149.84% in 2023, then sank 70.8% in 2024.
• Over 5 years, Raw Materials stood at $3.7 million in 2021, then soared by 51.97% to $5.6 million in 2022, then surged by 85.43% to $10.4 million in 2023, then climbed by 20.68% to $12.5 million in 2024, then sank by 33.48% to $8.3 million in 2025.
• The last three Raw Materials figures came in at $8.3 million (Q3 2025), $9.5 million (Q2 2025), and $11.8 million (Q1 2025), per Business Quant data.